Daro Largoza, MD
NPI 1063746014 · Research Study Specialist · New York, NY
Enrolled with Medicare as Order and Referring Only - General Practice · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Daro Largoza, MD is a Research Study Specialist provider in New York, NY (NPI 1063746014).
Provider details
- NPI number
- 1063746014
- Entity type
- Individual
- Primary specialty
- Research Study SpecialistOther Service Providers
- Credential
- MD
- Sex
- Male
- Sole proprietor
- Yes
- License
- 226955 (NY)
Specialties & taxonomies
Other Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure33% of score
16 yrs in NPPES registry
- Profile completeness33% of score
100% of core fields populated
- Practice footprint20% of score
1 documented practice location
- Open Payments transparency13% of score
Has Open Payments disclosures (2024)
Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 8 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Atorvastatin Calcium | 35 | 12 |
| Pantoprazole Sodium | 31 | 12 |
| Metformin Hcl | 19 | — |
| Lisinopril | 18 | — |
| Tamsulosin Hcl | 18 | — |
| Levothyroxine Sodium | 17 | — |
| Finasteride |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$109 across 1 record (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2009-09-23
- Last updated
- 2009-09-23
Frequently asked questions
- What is Daro Largoza's NPI number?
- Daro Largoza's National Provider Identifier (NPI) is 1063746014, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Daro Largoza's specialty?
- Daro Largoza is listed in the NPPES registry with a primary specialty of Research Study Specialist (Other Service Providers).
- Where is Daro Largoza located?
- Daro Largoza's practice location on file with NPPES is 50 West 34th. St., New York, NY 10001-2636.
- What is Daro Largoza's phone number?
- The practice phone number listed in the NPPES registry for Daro Largoza is (347) 526-1810.
- Does Daro Largoza accept Medicare?
- Daro Largoza is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Daro Largoza's NPI active?
- Yes — Daro Largoza's NPI (1063746014) is active in the NPPES registry as of the last update on 2009-09-23.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.